Home > All Topics > Emergency Department Management of Patients Taking Direct Oral Anticoagulant Agents
Emergency Department Management of Patients Taking Direct Oral Anticoagulant Agents
Below is a free preview. Log in or subscribe for full access. Or, get a free sample article Emergency Department Management of Abnormal Uterine Bleeding in the Nonpregnant Patient:
DOACs offer potential benefits over warfarin and other oral anticoagulants, including less need for monitoring and dietary restrictions, as well as the potential for reduced bleeding complications.
Dabigatran works by direct thrombin inhibition; rivaroxaban, apixaban, edoxaban, and betrixaban all work by factor Xa inhibition.
DOACs have a much shorter half-life than warfarin.
Prehospital care providers should ask patients about their use of anticoagulants, including the name of the drug, the dose, and the time the last dose was taken.